Sandoz

About Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars, dedicated to providing high-quality, affordable medicines to patients around the world. Established as a division of Novartis, Sandoz operates with a strong commitment to innovation and sustainability in healthcare.

The company focuses on developing and manufacturing a wide range of generic medications, ensuring that essential treatments are accessible to all. Sandoz’s portfolio includes a diverse array of therapeutic areas, such as oncology, cardiovascular health, and infectious diseases.

With a presence in over 140 countries, Sandoz leverages its extensive global network to meet the needs of healthcare providers and patients alike. The company invests significantly in research and development, striving to enhance the efficacy and safety of its products.

Sandoz is also at the forefront of biosimilars, offering alternatives to biologic therapies that can improve patient access to critical treatments. The company’s commitment to quality is reflected in its rigorous manufacturing standards and adherence to regulatory requirements.

In addition to its focus on product excellence, Sandoz is dedicated to corporate social responsibility, engaging in initiatives that promote health equity and environmental sustainability. The company collaborates with various stakeholders, including healthcare professionals and patient advocacy groups, to drive positive change in the healthcare landscape.

As part of its vision, Sandoz aims to be the most trusted partner in the healthcare community, delivering innovative solutions that enhance patient outcomes. Through its unwavering dedication to quality and accessibility, Sandoz continues to make a significant impact on global health.